- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pure Biologics SA (PUR1)
Pure Biologics SA stock price live, this page displays WA PUR1 stock exchange data. View the PUR1 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pure Biologics SA real time stock price chart below.
What Is the Pure Biologics SA Stock Price Today?
The Pure Biologics SA stock price today is 6.80.
What Is the Stock Symbol for Pure Biologics SA?
The stock symbol for Pure Biologics SA is ""PUR1.""
What Stock Exchange Does Pure Biologics SA Trade On?
Pure Biologics SA is listed and trades on the Warsaw stock exchange.
Is Pure Biologics SA a Good Stock to Buy?
Determining whether Pure Biologics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PUR1 quote. (ISIN: PLPRBLG00010)
What Is the Pure Biologics SA Stock Price Today?
The Pure Biologics SA stock price today is 6.80.
What Is the Stock Symbol for Pure Biologics SA?
The stock symbol for Pure Biologics SA is ""PUR1.""
What Stock Exchange Does Pure Biologics SA Trade On?
Pure Biologics SA is listed and trades on the Warsaw stock exchange.
Is Pure Biologics SA a Good Stock to Buy?
Determining whether Pure Biologics SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PUR1 quote. (ISIN: PLPRBLG00010)
Warsaw
Currency in PLN
6.80
-0.12(-1.73%)
Closed·
Fair Value
An estimate of a Pure Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.62
7.10
52 wk Range
2.49
33.20
PUR1 Scorecard
Full Analysis
Quickly burning through cash
PUR1 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Pure Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.627.10
52 wk Range
2.4933.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PUR1 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Pure Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Pure Biologics SA Company Profile
Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.
Compare PUR1 to Peers and Sector
Metrics to compare | PUR1 | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipPUR1PeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −5.9x | −0.6x | |
PEG Ratio | −0.04 | −0.09 | 0.00 | |
Price/Book | −2.1x | 2.2x | 2.6x | |
Price / LTM Sales | - | 9.8x | 3.3x | |
Upside (Analyst Target) | - | 50.0% | 39.0% | |
Fair Value Upside | Unlock | −5.5% | 4.9% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.28 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Pure Biologics Trade On?
Pure Biologics is listed and trades on the Warsaw Stock Exchange stock exchange.
What Is the Stock Symbol for Pure Biologics?
The stock symbol for Pure Biologics is "PUR1."
What Is the Pure Biologics Market Cap?
As of today, Pure Biologics market cap is 27.75M.
What Is Pure Biologics's Earnings Per Share (TTM)?
The Pure Biologics EPS (TTM) is -3.24.
From a Technical Analysis Perspective, Is PUR1 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Pure Biologics Stock Split?
Pure Biologics has split 0 times.
How Many Employees Does Pure Biologics Have?
Pure Biologics has 7 employees.
What is the current trading status of Pure Biologics (PUR1)?
As of 26 Aug 2025, Pure Biologics (PUR1) is trading at a price of 6.80, with a previous close of 6.92. The stock has fluctuated within a day range of 6.62 to 7.10, while its 52-week range spans from 2.49 to 33.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.